デジタル治療の世界市場分析:糖尿病、肥満、CVD、CNS疾患、呼吸器疾患、禁煙

◆英語タイトル:Digital Therapeutics Market By Application (Diabetes, Obesity, CVD, CNS Disorder, Respiratory Diseases, Smoking Cessation), By End Use (Patients, Providers, Payers, Employers), And Segment Forecasts, 2014 - 2025
◆商品コード:GVIEW708014
◆発行会社(調査会社):Grand View Research
◆発行日:2017年7月
◆ページ数:90
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥874,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,094,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Grand View Research(米国)が発行した本調査レポートでは、デジタル治療の世界市場について調査・分析し、デジタル治療の世界市場動向、デジタル治療の世界市場規模、市場予測、セグメント別デジタル治療市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global digital therapeutics market is anticipated to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. The growth of the market is catapulted by increasing incidences of chronic diseases, increasing emphasis on preventive healthcare, the need to curb healthcare expenditures, and added benefits offered by digital therapeutics. Rise in number of venture capitalists that are investing in the market is another factor that is accelerating its growth.
Digital therapeutics, commonly known as software-for drugs has been gaining much attention due to the number of benefits it offers to patients that utilize it. Continuous monitoring of patient’s vital stats, ability to ensure adherence to medications, prompt reminders are some of the most important benefits offered by digital therapeutics.

With an increase in the internet usage and dependency over smartphones, digital therapeutics offers easy tracking and monitoring of patients and their vital stats without intervention. This serves in a discrete and non-interventional manner to persuade individuals to adopt healthier lifestyles and improve physical well-being. Captivating design, extended assessment, and digital tracking are features that are attributing to increasing adoption of digital therapeutics by patients, employers, providers and others.

The North American region contributed to the largest market share owing to technologically advanced medical infrastructure and successful execution of ambulatory health in their healthcare system. Emerging countries like India, China and Brazil are also expected to flourish during the forecast period owing to adoption of enhanced healthcare infrastructure and medical technologies to curb the prevention of chronic diseases.

Further Key Findings From the Study Suggest:

The global digital therapeutics market $1.7 Billion in 2016 and is expected to grow at 21.0% CAGR from 2017 to 2025

Diabetes is expected to gain the largest market share on the basis of application owing to increasing incidence rates globally and preventive steps taken to reduce them

Obesity is also expected to account for a considerable market share due to various healthcare reforms to curb the disease initially and prevent further costs associated with the disease

The adoption of digital therapeutics offers reduction in healthcare costs associated with diseases like diabetes and obesity and are thus being used on an increasing scale

Digital tracking, continuous monitoring, and management of physical activity and eating habits are factors that are propelling the growth of the market

Increasing usage in preventive areas for a wide range of diseases and disorders like respiratory disorders, CVD, and CNS disease are attributes that are bringing about growth of the market

Patients accounted for the largest market share in the end-user’s segment owing to user-friendly interface and effective management of diseases

The North American region accounted for the highest revenue owing to technological advancement and healthcare expenditure to curb rise in number of chronic diseases

The Asia Pacific region is expected to garner considerable growth during the forecast period owing to increasing adoption of advanced healthcare technologies and rise in number of chronic diseases

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Scope & Assumptions
1.2. List of Data Sources
Chapter 2. Executive Summary
2.1. Digital Therapeutics: Market Summary
Chapter 3. Digital Therapeutics Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Digital Therapeutics: Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Key Opportunities Prioritized
3.4. Digital Therapeutics – SWOT Analysis, by Factor (political & legal, economic and technological)
3.5. Industry Analysis – Porter’s
3.6. Digital Therapeutics Market: Market Position Analysis, 2016
Chapter 4. Digital Therapeutics Market: Application Estimates & Trend Analysis
4.1. Digital Therapeutics Market: Application Movement Analysis
4.1.1. Diabetes
4.1.1.1. Diabetes market, 2014 – 2025 (USD Million)
4.1.2. Obesity
4.1.2.1. Obesity market, 2014 – 2025 (USD Million)
4.1.3. CVD
4.1.3.1. CVD market, 2014 – 2025 (USD Million)
4.1.4. CNS disease
4.1.4.1. CNS disease market, 2014 – 2025 (USD Million)
4.1.5. Respiratory diseases
4.1.5.1. Respiratory diseases market, 2014 – 2025 (USD Million)
4.1.6. Smoking cessation
4.1.6.1. Smoking cessation market, 2014 – 2025 (USD Million)
4.1.7. Others
4.1.7.1. Others market, 2014 – 2025 (USD Million)
Chapter 5. Digital Therapeutics Market: End use Estimates & Trend Analysis
5.1. Digital Therapeutics Market: End use Movement Analysis
5.2. Patients
5.2.1. Patients market, 2014 – 2025 (USD Million)
5.3. Providers
5.3.1. Providers market, 2014 – 2025 (USD Million)
5.4. Payers
5.4.1. Payers market, 2014 – 2025 (USD Million)
5.5. Employers
5.5.1. Employers market, 2014 – 2025 (USD Million)
5.6. Others
5.6.1. Others market, 2014 – 2025 (USD Million)
Chapter 6. Digital Therapeutics: Regional Estimates & Trend Analysis, by Application and End use
6.1. Digital Therapeutics Market Share (%) Analysis, by Region, 2016 & 2025
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.2.1.2. U.S. digital therapeutics market, by end use, 2014 – 2025 (USD Million)
6.2.2. Canada
6.2.2.1. Canada digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.2.2.2. Canada digital therapeutics market, by end use, 2014 – 2025 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. Germany digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.3.1.2. Germany digital therapeutics market, by end use, 2014 – 2025 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.3.2.2. U.K. digital therapeutics market, by end use, 2014 – 2025 (USD Million)
6.4. Asia-Pacific
6.4.1. China
6.4.1.1. China digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.4.1.2. China digital therapeutics market, by end use, 2014 – 2025 (USD Million)
6.4.2. India
6.4.2.1. India digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.4.2.2. India digital therapeutics market, by end use, 2014 – 2025 (USD Million)
6.5. Latin America
6.5.1. Brazil
6.5.1.1. Brazil digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.5.1.2. Brazil digital therapeutics market, by end use, 2014 – 2025 (USD Million)
6.5.2. Mexico
6.5.2.1. Mexico digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.5.2.2. Mexico digital therapeutics market, by end use, 2014 – 2025 (USD Million)
6.6. MEA
6.6.1. South Africa
6.6.1.1. South Africa digital therapeutics market, by application, 2014 – 2025 (USD Million)
6.6.1.2. South Africa digital therapeutics market, by end use, 2014 – 2025 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.1.1. Proteus Digital Health
7.1.1.1. Company overview
7.1.1.2. Product benchmarking
7.1.1.3. Strategic initiatives
7.1.2. Omada Health, Inc.
7.1.2.1. Company overview
7.1.2.2. Product benchmarking
7.1.2.3. Strategic initiatives
7.1.3. WellDoc Inc.
7.1.3.1. Company overview
7.1.3.2. Product benchmarking
7.1.3.3. Strategic initiatives
7.1.4. 2Morrow, Inc.
7.1.4.1. Company overview
7.1.4.2. Product benchmarking
7.1.4.3. Strategic initiatives
7.1.5. Livongo Health
7.1.5.1. Company overview
7.1.5.2. Product benchmarking
7.1.5.3. Strategic initiatives
7.1.6. Propeller Health
7.1.6.1. Company overview
7.1.6.2. Product benchmarking
7.1.6.3. Strategic initiatives
7.1.7. Twinehealth
7.1.7.1. Company overview
7.1.7.2. Product benchmarking
7.1.7.3. Strategic initiatives
7.1.8. Canary Health, Inc.
7.1.8.1. Company overview
7.1.8.2. Product benchmarking
7.1.8.3. Strategic initiatives
7.1.9. Mango Health, Inc.
7.1.9.1. Company overview
7.1.9.2. Product benchmarking
7.1.9.3. Strategic initiatives
7.1.10. Noom Health, Inc.
7.1.10.1. Company overview
7.1.10.2. Product bnchmarking
7.1.10.3. Strategic initiatives

List of Tables

1. Factors used in segment share estimation
2. List of secondary data sources
3. Primary interview details, by source
4. Primary interview details, by region
5. North America digital therapeutics market, by country, 2014 - 2025 (USD Million)
6. North America digital therapeutics market, by application, 2014 - 2025 (USD Million)
7. North America digital therapeutics market, by end use, 2014 - 2025 (USD Million)
8. U.S. digital therapeutics market, by application, 2014 - 2025 (USD Million)
9. U.S. digital therapeutics market, by end use, 2014 - 2025 (USD Million)
10. Canada digital therapeutics market, by application, 2014 - 2025 (USD Million)
11. Canada digital therapeutics market, by end use, 2014 - 2025 (USD Million)
12. Europe digital therapeutics market, by country, 2014 - 2025 (USD Million)
13. Europe digital therapeutics market, by application, 2014 - 2025 (USD Million)
14. Europe digital therapeutics market, by end use, 2014 - 2025 (USD Million)
15. Germany digital therapeutics market, by application, 2014 - 2025 (USD Million)
16. Germany digital therapeutics market, by end use, 2014 - 2025 (USD Million)
17. UK digital therapeutics market, by application, 2014 - 2025 (USD Million)
18. UK digital therapeutics market, by end use, 2014 - 2025 (USD Million)
19. Asia Pacific digital therapeutics market, by country, 2014 - 2025 (USD Million)
20. Asia Pacific digital therapeutics market, by application, 2014 - 2025 (USD Million)
21. Asia Pacific digital therapeutics market, by end use, 2014 - 2025 (USD Million)
22. China digital therapeutics market, by application, 2014 - 2025 (USD Million)
23. China digital therapeutics market, by end use, 2014 - 2025 (USD Million)
24. India digital therapeutics market, by application, 2014 - 2025 (USD Million)
25. India digital therapeutics market, by end use, 2014 - 2025 (USD Million)
26. Latin America digital therapeutics market, by country, 2014 - 2025 (USD Million)
27. Latin America digital therapeutics market, by application, 2014 - 2025 (USD Million)
28. Latin America digital therapeutics market, by end use, 2014 - 2025 (USD Million)
29. Brazil digital therapeutics market, by application, 2014 - 2025 (USD Million)
30. Brazil digital therapeutics market, by end use, 2014 - 2025 (USD Million)
31. Mexico digital therapeutics market, by application, 2014 - 2025 (USD Million)
32. Mexico digital therapeutics market, by end use, 2014 - 2025 (USD Million)
33. MEA digital therapeutics market, by country, 2014 - 2025 (USD Million)
34. MEA digital therapeutics market, by application, 2014 - 2025 (USD Million)
35. MEA digital therapeutics market, by end use, 2014 - 2025 (USD Million)
36. South Africa digital therapeutics market, by application, 2014 - 2025 (USD Million)
37. South Africa digital therapeutics market, by end use, 2014 - 2025 (USD Million)

List of Figures

1. Market summary
2. Market trends & outlook
3. Market segmentation & scope
4. Market driver relevance analysis (Current & future impact)
5. Key opportunities prioritized
6. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
7. Porter’s Five Forces Analysis
8. Digital therapeutics market: Application outlook key takeaways
9. Digital therapeutics market: Application movement analysis
10. Diabetes market, 2014 - 2025 (USD Million)
11. Obesity market, 2014 - 2025 (USD Million)
12. CVD market, 2014 - 2025 (USD Million)
13. CNS disease market, 2014 - 2025 (USD Million)
14. Respiratory diseases market, 2014 - 2025 (USD Million)
15. Smoking cessation market, 2014 - 2025 (USD Million)
16. Others market, 2014 - 2025 (USD Million)
17. Digital therapeutics market: End use outlook key takeaways
18. Digital therapeutics market: End use movement analysis
19. Patients market, 2014 - 2025 (USD Million)
20. Providers market, 2014 - 2025 (USD Million)
21. Payers market, 2014 - 2025 (USD Million)
22. Employers market, 2014 - 2025 (USD Million)
23. Others market, 2014 - 2025 (USD Million)
24. Regional market place: Key takeaways
25. Regional outlook, 2015 & 2025

【レポートのキーワード】

デジタル治療、糖尿病治療、肥満治療、CVD治療、CNS疾患治療、呼吸器疾患治療、禁煙治療

★調査レポート[デジタル治療の世界市場分析:糖尿病、肥満、CVD、CNS疾患、呼吸器疾患、禁煙] (コード:GVIEW708014)販売に関する免責事項を必ずご確認ください。
★調査レポート[デジタル治療の世界市場分析:糖尿病、肥満、CVD、CNS疾患、呼吸器疾患、禁煙]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆